Nektar Therapeutics
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -174.2% | -174.2% | -27.0% |
| FY2017 | -110.1% | -110.1% | -19.0% |
| FY2018 | 39.7% | 39.7% | 31.7% |
| FY2019 | -31.4% | -31.4% | -22.3% |
| FY2020 | -41.3% | -41.3% | -28.9% |
| FY2021 | -77.1% | -77.1% | -46.9% |
| FY2022 | -100.4% | -100.4% | -51.8% |
| FY2023 | -210.8% | -210.8% | -69.4% |
| FY2024 | -195.9% | -195.9% | -39.2% |
| FY2025 | -182.6% | -182.6% | -58.5% |